Results 41 to 50 of about 1,384 (118)

Computationally Guided Design of a Soluble, Abundant and Functional AnfH Variant for the Expression of Fe‐Only Nitrogenase in Plant Mitochondria

open access: yesPlant Biotechnology Journal, Volume 23, Issue 12, Page 5622-5634, December 2025.
Design of more soluble AnfH variants for expression in plant mitochondria. ABSTRACT Engineering nitrogenase directly into crops is a long‐held aspiration in plant biotechnology. Of the three types, the Fe‐only nitrogenase is a promising engineering target, as it has a simpler maturation pathway than the MoFe‐ and VFe‐nitrogenases and does not require ...
Christina M. Gregg   +8 more
wiley   +1 more source

Specific and off-target immune responses following COVID-19 vaccination with ChAdOx1-S and BNT162b2 vaccines—an exploratory sub-study of the BRACE trialResearch in context

open access: yesEBioMedicine
Summary: Background: The COVID-19 pandemic led to the rapid development and deployment of several highly effective vaccines against SARS-CoV-2. Recent studies suggest that these vaccines may also have off-target effects on the immune system.
Nicole L. Messina   +586 more
doaj   +1 more source

Interplay Between Salt Tectonics and a Large Igneous Province in the Espírito Santo Basin (Brazil)

open access: yesTectonics, Volume 44, Issue 11, November 2025.
Abstract Salt tectonics provinces host numerous resources and are now targeted as potential areas of development for energy storage capacities such as underground storage in salt caverns. Sedimentary basins containing salt structures are common at passive margins where volcanic rocks, emplaced either during the lithospheric breakup or the post‐rift ...
Naïm A. Celini, Charlie Kergaravat
wiley   +1 more source

Bacille Calmette-Guérin vaccination to prevent febrile and respiratory illness in adults (BRACE): secondary outcomes of a randomised controlled phase 3 trialResearch in context

open access: yesEClinicalMedicine
Summary: Background: Bacille Calmette-Guérin (BCG) vaccination has off-target (non-specific) effects that are associated with protection against unrelated infections and decreased all-cause mortality in infants.
Laure F. Pittet   +598 more
doaj   +1 more source

Post-acute COVID-19 outcomes including participant-reported long COVID: amubarvimab/romlusevimab versus placebo in the ACTIV-2 trialResearch in context

open access: yesEClinicalMedicine
Summary: Background: It is unknown if early COVID-19 monoclonal antibody (mAb) therapy can reduce risk of Long COVID. The mAbs amubarvimab/romlusevimab were previously demonstrated to reduce risk of hospitalization/death by 79%.
Teresa H. Evering   +320 more
doaj   +1 more source

Thank You to Our 2025 Peer Reviewers

open access: yes
Geophysical Research Letters, Volume 53, Issue 6, 28 March 2026.
Kristopher Karnauskas   +40 more
wiley   +1 more source

Characteristics and outcomes of COVID-19 patients admitted to hospital with and without respiratory symptoms

open access: yesHeliyon
Background: COVID-19 is primarily known as a respiratory illness; however, many patients present to hospital without respiratory symptoms. The association between non-respiratory presentations of COVID-19 and outcomes remains unclear.
Barbara Wanjiru Citarella   +1858 more
doaj   +1 more source

Deep learning enhanced ALPS reveals genetic and environmental factors of brain glymphatic functionResearch in context

open access: yesEBioMedicine
Summary: Background: The glymphatic system plays a critical role in brain waste clearance and health. Diffusion tensor imaging along the perivascular space (DTI-ALPS) is an emerging approach to assess glymphatic function, but manual analysis is limited ...
Cha Lin   +1747 more
doaj   +1 more source

Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trialResearch in context

open access: yesEClinicalMedicine
Summary: Background: Low dose corticosteroids (e.g., 6 mg dexamethasone) have been shown to reduce mortality for hypoxic COVID-19 patients. We have previously reported that higher dose corticosteroids cause harm in patients with clinical hypoxia but not
O. Abani   +8023 more
doaj   +1 more source

Poster Sessions

open access: yes
HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Home - About - Disclaimer - Privacy